Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 3
2004 9
2005 9
2006 10
2007 6
2008 9
2009 12
2010 11
2011 16
2012 23
2013 39
2014 20
2015 25
2016 30
2017 19
2018 21
2019 20
2020 19
2021 29
2022 28
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between the magnitude of body mass index reductions and remission in patients with type 2 diabetes in real world settings: Analysis of nationwide patient registry in Japan (JDDM74).
Fujihara K, Khin L, Murai K, Yamazaki Y, Tsuruoka K, Yagyuda N, Yamazaki K, Maegawa H, Tanaka S, Kodama S, Sone H; JDDM Study Group. Fujihara K, et al. Among authors: maegawa h. Diabetes Obes Metab. 2023 Nov;25(11):3125-3135. doi: 10.1111/dom.15206. Epub 2023 Jul 7. Diabetes Obes Metab. 2023. PMID: 37417395
O-linked N-acetylglucosamine modification is essential for physiological adipose expansion induced by high-fat feeding.
Nakamoto A, Ohashi N, Sugawara L, Morino K, Ida S, Perry RJ, Sakuma I, Yanagimachi T, Fujita Y, Ugi S, Kume S, Shulman GI, Maegawa H. Nakamoto A, et al. Among authors: maegawa h. Am J Physiol Endocrinol Metab. 2023 Jul 1;325(1):E46-E61. doi: 10.1152/ajpendo.00263.2022. Epub 2023 May 24. Am J Physiol Endocrinol Metab. 2023. PMID: 37224467
Reduced incidence of cardiovascular disease in patients with type 2 diabetes through the integrated improvement of diabetes care by comparing two prospective observational cohorts in real-world clinical practice (JDDM 72).
Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, Maeda H, Ohtaki M, Obata H, Sone H, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. Among authors: maegawa h. Diabetes Res Clin Pract. 2023 Aug;202:110674. doi: 10.1016/j.diabres.2023.110674. Epub 2023 Apr 21. Diabetes Res Clin Pract. 2023. PMID: 37086752
Ketone bodies: A double-edged sword for mammalian life span.
Tomita I, Tsuruta H, Yasuda-Yamahara M, Yamahara K, Kuwagata S, Tanaka-Sasaki Y, Chin-Kanasaki M, Fujita Y, Nishi E, Katagiri H, Maegawa H, Kume S. Tomita I, et al. Among authors: maegawa h. Aging Cell. 2023 Jun;22(6):e13833. doi: 10.1111/acel.13833. Epub 2023 Apr 14. Aging Cell. 2023. PMID: 37060184 Free PMC article.
Annual trends in glycemic control and prescribing patterns in diabetic treatment according to age in Japanese patients with type 2 diabetes between 2012 and 2019 (JDDM 71).
Miyazawa I, Yokoyama H, Yagi N, Araki SI, Morino K, Kume S, Shirabe S, Yamazaki K, Maegawa H. Miyazawa I, et al. Among authors: maegawa h. Diabetes Res Clin Pract. 2023 Apr;198:110599. doi: 10.1016/j.diabres.2023.110599. Epub 2023 Feb 26. Diabetes Res Clin Pract. 2023. PMID: 36849048
Coexistence of Pheochromocytoma and Primary Aldosteronism due to Multiple Aldosterone-producing Micronodules in the Ipsilateral Adrenal Gland.
Ugi S, Yonishi M, Sato D, Nakaizumi N, Horikawa O, Fujita Y, Inoue K, Wada A, Kageyama S, Kawauchi A, Hino M, Noujima M, Yamazaki Y, Sasano H, Maegawa H. Ugi S, et al. Among authors: maegawa h. Intern Med. 2023 Sep 15;62(18):2685-2691. doi: 10.2169/internalmedicine.1012-22. Epub 2023 Feb 1. Intern Med. 2023. PMID: 36725043 Free PMC article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
316 results